Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Catalyst Pharmaceuticals Q2 2024 Adj. EPS $0.56 Beats $0.26 Estimate, Sales $122.710M Beat $111.866M Estimate

Author: Benzinga Newsdesk | August 07, 2024 04:52pm
Catalyst Pharmaceuticals (NASDAQ:CPRX) reported quarterly earnings of $0.56 per share which beat the analyst consensus estimate of $0.26 by 115.38 percent. This is a 5.66 percent increase over earnings of $0.53 per share from the same period last year. The company reported quarterly sales of $122.710 million which beat the analyst consensus estimate of $111.866 million by 9.69 percent. This is a 23.23 percent increase over sales of $99.582 million the same period last year.

Posted In: CPRX


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist